C5E:PA:PA-Amundi Stoxx Europe 50 UCITS (EUR)

ETF | Others |

Last Closing

USD 127.06

Change

+0.90 (+0.71)%

Market Cap

USD 0.54B

Volume

343.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.22 (-0.46%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.70 (-0.12%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.21 (+0.05%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.04 (+0.10%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.54 (+0.60%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

N/A

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.43 (+0.12%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-0.06 (-0.10%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.22 (+0.14%)

USD 5.17B

ETFs Containing C5E:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.20% 87% B+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.20% 87% B+ 78% C+
Trailing 12 Months  
Capital Gain 12.88% 51% F 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.88% 49% F 64% D
Trailing 5 Years  
Capital Gain 55.39% 69% C- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.39% 68% D+ 74% C
Average Annual (5 Year Horizon)  
Capital Gain 13.76% 74% C 73% C
Dividend Return 13.76% 72% C 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.29% 72% C 46% F
Risk Adjusted Return 165.97% 99% N/A 50% F
Market Capitalization 0.54B 65% D 69% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike